[1] |
ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing.
Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
|
[2] |
LIU Nannan, XI Yalin, CHEN Zhe.
One Case of Adrenocortical Insufficiency Caused by Cadonilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 109-112.
|
[3] |
ZHANG Caixia, ZHOU Yi, TAN Lu, CHEN Wenming, LIU Yang, YOU Yu.
Pharmaceutical care of pulmonary aspergillus infection secondary to sepsis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1064-1067.
|
[4] |
YAN Yan, LIU Naiyi, QIAO Ling, ZHANG Yi, YANG Chen.
One case of fulminant type 1 diabetes mellitus induced by allopurinol tablets hypersensitivity syndrome
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1068-1070.
|
[5] |
ZHANG Qian, YUN Yuan, HE Lian.
Pharmaceutical care of hyperprolactinemia in a patient induced by risperidone
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 936-938.
|
[6] |
LIN Yanxin, LIU Yanhui, DONG Jing, YAO Jiachen, LI Wenyan.
Pharmaceutical care of acute liver injury in a patient with colon cancer induced by irinotecan
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 693-696.
|
[7] |
LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong.
Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456.
|
[8] |
LIU Qi, ZHANG Yufeng, LUO Hao, LI Xin.
Analysis of the rationality and safety of clinical application of anrotinib in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 329-334.
|
[9] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[10] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[11] |
LIU Xin, WANG Guojun.
Pharmacological Care of Hypertension Due to Glucocorticoid Drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1303-1305.
|
[12] |
SHEN Jianghua, KONG Chao, PAN Fumin, CHU Yanqi.
Pharmaceutical care of a case with vertebral osteomyelitis of Coxiella burnetiid
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1166-1168.
|
[13] |
ZHANG Xialan, YUAN Jing, WU Bin, QIN Yuanyuan.
Medications of apatinib mesylate in patients with malignant tumors
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 927-932.
|
[14] |
WANG Ran, LI Yifan, LIU Xiaoyan, FENG Xin.
One case of pharmaceutical care of drug exposure during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 933-934.
|
[15] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|